This study has shed light upon the differential PIK3CA mutational profiles between relapse and primary tumors, and their associations to clinicopathological variables, especially lymph node status, in a unique paired cohort of patients with confirmed endocrine-resistant breast cancer. Here, PIK3CA is linked to breast cancer.